Success Stories: South Korean Research Specialist in the field of Dermatology with Approved NIW will File an I-485 to Obtain a Green Card
Client’s Testimonial:
“I’m excited to share the news that my approval notice for I-140 has arrived in mail. Thank you for putting together a strong case on my behalf!”
On June 22nd, 2019, we received another EB-2 NIW (National Interest Waiver) approval for a Research Specialist in the Field of Dermatology (Approval Notice).
General Field: Dermatology
Position at the Time of Case Filing: Research Specialist
Country of Origin: South Korea
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: June 22nd, 2019
Processing Time: 6 months, 12 days
Case Summary:
A South Korean research specialist in the field of dermatology hired North America Immigration Law Group (WeGreend.com) to build and file a customized EB-2 NIW (National Interest Waiver) petition on her behalf. As exemplified by the over 15,000 petition approvals we had helped our previous clients, she knew that we would offer comprehensive advice and successfully petition her case. A thorough review of our client’s academic profile helped us establish that her specialized research is focused on examining the pathogenesis and treatment of dermatological issues such as vitiligo and atopic dermatitis. With our help, her case was approved in less than 7 months.
To prepare a strong NIW case for our client, we first assisted our client to select appropriate recommenders. The letters signed by notable experts working in her field staunchly supported the approval of our client’s NIW petition. According to one of these recommenders, our client‘s work is important to the US as it “promotes the health and welfare of the American people in the face of the increasing burden of atopic dermatitis. According to a paper from Dermatology Clinics, between 6% to nearly 13% of children in the United States have atopic dermatitis, which is substantially higher than the rate in many other countries. [Client]’s work has established a new treatment that is especially beneficial in children, making her work a boon to the United States”.
Through developing novel treatment approaches to treat chronic condition which causes severe discomfort in the human skin, our client has helped establish the long-term effectiveness and safety of subcutaneous allergen immunotherapy, which offers a new treatment option to individuals with moderate and severe atopic dermatitis. Her remarkable publication and citation record also deserves special mention. At the time of filing, her publications include 14 peer-reviewed journal articles, 7 letters to the editor, and 5 case reports; these works have also gone on to influence her peers and colleagues, which have amassed a total of 249 citations.
We are pleased that our hard work paid off and that our client secured the national interest waiver. We thank her for not only choosing us to represent her NIW case, but also retaining our firm to file I-485 application for her and her dependent(s) to adjust their status for permanent residency.